市场调查报告书
商品编码
1530834
2030 年医疗保健自动化市场预测:按技术、应用、最终用户和地区进行的全球分析Healthcare Automation Market Forecasts to 2030 - Global Analysis By Technology (Robotics, Artificial Intelligence, Internet of Medical Things, Big Data and Analytics, Blockchains and Other Technologies), Application, End User and by Geography |
根据 Stratistics MRC 的数据,2024 年全球医疗保健自动化市场规模为 441.5 亿美元,预测期内复合年增长率为 12.0%,到 2030 年将达到 871.5 亿美元。
医疗保健自动化一词描述了应用软体和技术来自动执行重复性任务并改善医疗产业的工作流程。这些范围从自动申请和电子健康记录( EHR) 管理到先进的机器人手术和人工智慧驱动的诊断。医疗保健提供者可以透过自动化耗时且重复的任务来提高工作效率、减少错误并花更多时间患者照护。此外,自动化提高了资料的可及性和准确性,有助于更好的决策并改善患者的治疗结果。
据美国医学会称,医疗保健自动化有可能显着减轻医生的行政负担,使他们能够更加专注于直接患者护理和改善整体医疗保健服务。
对有效医疗服务的需求不断增长
人口老化、慢性病的流行以及患者期望的提高都导致医疗保健领域服务需求的增加。医疗保健提供者面临着满足这些需求并提供有效、高品质护理的压力。自动化技术有助于管理患者负担、减少等待时间并确保及时的医疗干预。此外,医疗保健自动化优化了工作流程并减轻了管理负担,使医务人员能够更多地关注患者照护,最终改善患者的治疗结果。
高入门价
实施医疗保健自动化技术需要在硬体、软体和基础设施方面进行大量初始投资。对于预算有限的小型诊所和设施来说,这些费用可能令人望而却步。此外,与员工培训、系统维护以及与当前技术整合相关的成本也增加了负担。此外,虽然从长远来看,自动化可以提高效率并降低成本,但它可能会带来巨大的前期成本,特别是对于资源不足或偏远的医疗保健提供者而言。
医学研究的新方法
医学研究将透过自动化取得巨大进步。自动化资料收集和分析可以缩短临床试验和研究的时间。医疗领域的巨量资料可以透过人工智慧和机器学习演算法进行处理,以揭示人类无法揭示的趋势和见解。结果,可能会发现新的治疗方法、药物和治疗方法。自动化也有助于确保研究资料管理的准确性和法规遵循。
法律和道德问题
医疗保健领域的自动化,特别是人工智慧和机器学习的应用,带来了重大的道德和法律问题。必须仔细考虑演算法偏差、自动决策的透明度以及人工智慧系统的课责等问题。例如,如果AI系统出现诊断错误,则很难确定责任和课责。确保自动化系统的开发和使用符合道德规范,需要不断审查、相关人员的全面参与、制定精确的道德标准以及法律体制的实施。此外,平衡自动化的好处与道德考量对于维持医疗保健服务的公平和信任至关重要。
COVID-19 大流行为世界各地的医疗保健系统带来了前所未有的挑战,导致医疗保健自动化的采用显着加速。远端医疗平台、自动化诊断工具和远端监控系统的快速部署推动了对有效且可扩展的解决方案的需求,以管理患者照护、减少医护人员的工作量并确保服务的连续性。此外,自动化简化了管理流程,实现了远端患者交互,并改善了资料管理,减轻了负担过重的医疗机构的压力。
人工智慧产业预计将在预测期内成为最大的产业
人工智慧(AI)领域在医疗保健自动化市场中占有最大份额。人工智慧在个人化医疗、诊断和治疗计划方面的广泛应用正在推动其主导地位。人工智慧系统能够以无与伦比的精度评估复杂的医疗资料、提供预后预测并增强决策程序。这包括处理医疗记录的自然语言处理、预测患者结果的预测分析以及放射学中的影像识别等应用。此外,人工智慧 (AI) 因其适应性和改变医疗保健运营和交付的许多方面的能力而成为医疗保健自动化发展的主要参与者。
诊断监控自动化产业预计在预测期内复合年增长率最高
在医疗保健自动化市场中,诊断和监测自动化领域的复合年增长率最高。对先进诊断设备和持续病患监测计划不断增长的需求正在推动该市场的爆炸性增长。穿戴式健康监测器、人工智慧驱动的诊断系统和遥感探测技术只是改变医疗保健专业人员识别和治疗疾病方式的创新的几个例子。此外,这些技术提供即时资料、提高诊断准确性并能够主动管理健康状况,正在推动大量投资和领域扩张。
医疗保健自动化市场由北美主导。这一优势得益于该地区自动化解决方案的高采用率、大量的技术投资和先进的医疗基础设施。由于重要科技公司的存在、大量的研发计划以及促进商业发展的政府法规,北美仍保持领先地位。此外,该地区在医疗保健自动化领域的巨大市场占有率是由该行业对创新解决方案的强劲需求、稳定的法规环境以及改善患者治疗结果和医疗保健效率的承诺所推动的。
欧洲的医疗保健自动化市场也以相当快的速度扩张,复合年增长率最高。这一增长是由该地区日益关注医疗保健的技术创新和数位转型所推动的。为了应对人口老化带来的挑战、提高业务效率并提高护理质量,欧洲国家正在大力投资尖端自动化技术。此外,欧盟的支持性法规环境、大量的研发资金以及综合卫生系统的推广进一步加速了自动化解决方案的采用。
According to Stratistics MRC, the Global Healthcare Automation Market is accounted for $44.15 billion in 2024 and is expected to reach $87.15 billion by 2030 growing at a CAGR of 12.0% during the forecast period. The term healthcare automation describes the application of software and technology to automate repetitive tasks and improve workflow in the medical industry. This can range from automated billing and the administration of electronic health records (EHRs) to sophisticated robotic surgery and AI-driven diagnostics. Healthcare providers can increase productivity, lower errors, and devote more time to patient care by automating time-consuming and repetitive tasks. Additionally, automation improves the accessibility and accuracy of data, which facilitates better decision-making and better patient outcomes.
According to the American Medical Association, healthcare automation has the potential to significantly reduce administrative burdens on physicians, allowing them to focus more on direct patient care and improving overall healthcare delivery.
Growing need for effective medical services
The aging population, the prevalence of chronic diseases, and the rising expectations of patients are all contributing factors to the growing demand for services in the healthcare sector. Healthcare providers are under pressure to provide effective, high-quality care in response to this demand. Automation technologies help to manage patient loads, shorten wait times, and guarantee prompt medical interventions. Moreover, healthcare automation helps medical staff focus more on patient care by optimizing workflows and lowering administrative burdens, which eventually improves patient outcomes.
High starting prices
Healthcare automation technology implementation necessitates a large initial hardware, software, and infrastructure investment. These expenses may be unaffordable for smaller medical practices and facilities with tighter budgets. The costs associated with employee training, system maintenance, and integration with current technologies can also increase the burden. Furthermore, automation may increase efficiency and reduce costs in the long run, but it can come with a significant upfront cost, especially for underfunded or remote healthcare providers.
New approaches to medical research
Medical research can progress significantly with the help of automation. Clinical trial and research study times can be shortened by using automated data collection and analysis. Big data in the medical field can be processed by AI and machine learning algorithms, which can reveal trends and insights that are impossible for humans to see. Novel therapies, medications, and treatments may be found as a result of this. Automation also helps to ensure accuracy and regulatory compliance in the management of research data.
Legal and ethical concerns
The application of automation in healthcare, especially AI and machine learning, presents significant moral and legal issues. Careful consideration must be given to matters like algorithmic bias, automated decision-making transparency, and AI system accountability. Determining liability and accountability, for instance, can be difficult if an AI system makes a diagnostic error. It takes constant examination, inclusive stakeholder engagement, the development of precise ethical standards, and the implementation of legal frameworks to guarantee that automated systems are developed and utilized ethically. Additionally, to preserve equity and trust in the provision of healthcare, it is crucial to strike a balance between the advantages of automation and moral considerations.
The COVID-19 pandemic brought about unprecedented challenges for healthcare systems worldwide, which in turn significantly accelerated the adoption of healthcare automation. The quick adoption of telehealth platforms, automated diagnostic tools, and remote monitoring systems was motivated by the need for effective and scalable solutions to manage patient care, lessen the workload on healthcare professionals, and ensure continuity of services. Furthermore, automation streamlined administrative processes, enabled remote patient interactions, and improved data management, all of which relieved pressure on overburdened healthcare facilities.
The Artificial Intelligence segment is expected to be the largest during the forecast period
In the market for healthcare automation, the artificial intelligence (AI) segment has the largest share. The wide range of uses of AI in personalized medicine, diagnosis, and treatment planning is what propels its dominance. AI systems possess the ability to evaluate intricate medical data, offer prognostications, and bolster decision-making procedures with unparalleled precision. This covers uses like natural language processing for processing medical records, predictive analytics for patient outcomes, and image recognition in radiology. Moreover, artificial intelligence (AI) is a key player in the growth of healthcare automation due to its adaptability and capacity to change many facets of healthcare operations and delivery.
The Diagnostics & Monitoring Automation segment is expected to have the highest CAGR during the forecast period
In the healthcare automation market, the Diagnostics & Monitoring Automation segment has the highest CAGR. The rising need for sophisticated diagnostic instruments and ongoing patient monitoring programs is driving this market's explosive expansion. Wearable health monitors, AI-driven diagnostic systems, and remote sensing technologies are just a few examples of innovations that are changing the way healthcare professionals identify and treat illnesses. Additionally, significant investment and sector expansion are being driven by these technologies, which provide real-time data, enhance diagnostic accuracy, and enable proactive management of health conditions.
The market for healthcare automation is dominated by North America. This dominance is a result of the region's highly adopted automation solutions, substantial technological investments, and sophisticated healthcare infrastructure. North America is still in the lead because of the existence of significant technology companies, a plethora of R&D projects, and pro-business government regulations. Furthermore, the region's sizable market share in healthcare automation is also attributed to the strong demand for creative solutions in the field, a stable regulatory environment, and a commitment to enhancing patient outcomes and healthcare efficiency.
The healthcare automation market is expanding at a significant rate in Europe as well, with the highest CAGR. The region's growing focus on technology innovation and the digital transformation of healthcare is what is causing this growth. In order to address the issues posed by an aging population, increase operational efficiencies, and improve care quality, European nations are making significant investments in cutting-edge automation technologies. Moreover, the adoption of automation solutions is being further fueled by the EU's supportive regulatory environment, significant funding for research and development, and the push for integrated healthcare systems.
Key players in the market
Some of the key players in Healthcare Automation market include Swisslog Holding AG, Cerner, Stryker Corporation, Accuray, Inc., Tecan Group Ltd., Koninklijke Philips N.V., GE Healthcare, Roche Diagnostics, Intuitive Surgical, Inc., Danaher Corporation, Siemens Healthineers, Medtronic plc and Philips Healthcare.
In July 2024, GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC's (Intelligent Ultrasound) clinical artificial intelligence (AI) software business for total consideration of approximately $51 million. Intelligent Ultrasound is a leader in integrated AI-driven image analysis tools designed to make ultrasound smarter and more efficient.
In June 2024, Accuray Incorporated announced an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-party support designed to enhance their department's capabilities.
In June 2024, Stryker, a global leader in medical technologies, announced the signing of a definitive agreement to acquire all of the issued and outstanding shares of Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures.